Connection
Gregory Schwartz to Drug Interactions
This is a "connection" page, showing publications Gregory Schwartz has written about Drug Interactions.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.038 |
|
|
|
-
Koomen JV, Heerspink HJL, Schrieks IC, Schwartz GG, Lincoff AM, Nicholls SJ, Svensson A, Wedel H, Weichert A, Grobbee DE, Stevens J. Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trial. Diabetes Obes Metab. 2020 01; 22(1):30-38.
Score: 0.038